The University of Southampton
University of Southampton Institutional Repository

Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency.

Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency.
Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency.
PurposeLamb-Shaffer syndrome (LAMSHF) is a neurodevelopmental disorder described in just over two dozen patients with heterozygous genetic alterations involving SOX5, a gene encoding a transcription factor regulating cell fate and differentiation in neurogenesis and other discrete developmental processes. The genetic alterations described so far are mainly microdeletions. The present study was aimed at increasing our understanding of LAMSHF, its clinical and genetic spectrum, and the pathophysiological mechanisms involved.MethodsClinical and genetic data were collected through GeneMatcher and clinical or genetic networks for 41 novel patients harboring various types ofSOX5 alterations. Functional consequences of selected substitutions were investigated.ResultsMicrodeletions and truncating variants occurred throughout SOX5. In contrast, most missense variants clustered in the pivotal SOX-specific high-mobility-group domain. The latter variants prevented SOX5 from binding DNA and promoting transactivation in vitro, whereas missense variants located outside the high-mobility-group domain did not. Clinical manifestations and severity varied among patients. No clear genotype-phenotype correlations were found, except that missense variants outside the high-mobility-group domain were generally better tolerated.ConclusionsThis study extends the clinical and genetic spectrum associated with LAMSHF and consolidates evidence that SOX5 haploinsufficiency leads to variable degrees of intellectual disability, language delay, and other clinical features.
1098-3600
524-537
Zawerton, Ash
697f0914-b1c3-46cb-a23a-3f6da387f4ba
Mignot, Cyril
d19e53ee-791c-44cc-9247-da54e009315c
Sigafoos, Ashley
9ec5a531-c256-458d-83e6-d9a320997a80
Blackburn, Patrick
91c42051-df7d-43af-bacc-a11c31c6522a
Salter, Claire
fd214de9-a3f8-4db7-93e5-64d399182975
al, et
df099e87-31d7-4ccf-a9fa-b92a380537f9
Zawerton, Ash
697f0914-b1c3-46cb-a23a-3f6da387f4ba
Mignot, Cyril
d19e53ee-791c-44cc-9247-da54e009315c
Sigafoos, Ashley
9ec5a531-c256-458d-83e6-d9a320997a80
Blackburn, Patrick
91c42051-df7d-43af-bacc-a11c31c6522a
Salter, Claire
fd214de9-a3f8-4db7-93e5-64d399182975
al, et
df099e87-31d7-4ccf-a9fa-b92a380537f9

Zawerton, Ash, Mignot, Cyril, Sigafoos, Ashley, Blackburn, Patrick, Salter, Claire and al, et (2019) Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency. Genetics in Medicine, 22 (3), 524-537. (doi:10.1038/s41436-019-0657-0).

Record type: Article

Abstract

PurposeLamb-Shaffer syndrome (LAMSHF) is a neurodevelopmental disorder described in just over two dozen patients with heterozygous genetic alterations involving SOX5, a gene encoding a transcription factor regulating cell fate and differentiation in neurogenesis and other discrete developmental processes. The genetic alterations described so far are mainly microdeletions. The present study was aimed at increasing our understanding of LAMSHF, its clinical and genetic spectrum, and the pathophysiological mechanisms involved.MethodsClinical and genetic data were collected through GeneMatcher and clinical or genetic networks for 41 novel patients harboring various types ofSOX5 alterations. Functional consequences of selected substitutions were investigated.ResultsMicrodeletions and truncating variants occurred throughout SOX5. In contrast, most missense variants clustered in the pivotal SOX-specific high-mobility-group domain. The latter variants prevented SOX5 from binding DNA and promoting transactivation in vitro, whereas missense variants located outside the high-mobility-group domain did not. Clinical manifestations and severity varied among patients. No clear genotype-phenotype correlations were found, except that missense variants outside the high-mobility-group domain were generally better tolerated.ConclusionsThis study extends the clinical and genetic spectrum associated with LAMSHF and consolidates evidence that SOX5 haploinsufficiency leads to variable degrees of intellectual disability, language delay, and other clinical features.

This record has no associated files available for download.

More information

Published date: 3 October 2019

Identifiers

Local EPrints ID: 509391
URI: http://eprints.soton.ac.uk/id/eprint/509391
ISSN: 1098-3600
PURE UUID: 3c5d9fcb-c900-49c4-aa52-bf603b102f43
ORCID for Claire Salter: ORCID iD orcid.org/0000-0002-2494-1644

Catalogue record

Date deposited: 19 Feb 2026 17:58
Last modified: 20 Feb 2026 03:12

Export record

Altmetrics

Contributors

Author: Ash Zawerton
Author: Cyril Mignot
Author: Ashley Sigafoos
Author: Patrick Blackburn
Author: Claire Salter ORCID iD
Author: et al

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×